home / stock / goss / goss news

GOSS News and Press, Gossamer Bio Inc. From 08/05/20

Stock Information
Company Name: Gossamer Bio Inc.
Stock Symbol: GOSS
Market: NYSE
Website: gossamerbio.com
Menu
GOSS GOSS Quote GOSS Short GOSS News GOSS Articles GOSS Message Board
Get GOSS Alerts

News, Short Squeeze, Breakout and More Instantly...
GOSS - Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual Conference

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will present four posters with data relevant to...
GOSS - Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma

CINCINNATI, June 08, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that it is hosting a key op...

GOSS - Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the presentation of positive safety and biomarker data ...

GOSS - Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients

SAN FRANCISCO and CINCINNATI, May 27, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) and Quantum Leap Healthcare Collaborative™ (Quantum Leap) announced today an agreement has been reached to evaluate razuprotafib in a new randomized, in...
GOSS - DVAX, ABUS, ACB and SRNE among midday movers

 Gainers: Nano Dimension NNDM  +272% . More news on: ShiftPixy, Inc., Mercurity Fintech Holding Inc., Iterum Therapeutics plc, Stocks on the move, , Read more ...

GOSS - SAN, CVNA among premarket losers

Gamida Cell (NASDAQ: GMDA )  -25%  after pricing equity offering. More news on: Gamida Cell Ltd., Gossamer Bio, Inc., Bellerophon Therapeutics, Inc., Stocks on the move, , Read more ...

GOSS - Gossamer Bio Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the pricing of its underwritten public offering of 9,433,...
GOSS - ACB, BIDU, IQ and CLVS among after-hours movers

Gainers: ABUS   +46.5% .   DAC   +10.1% . TNP   +9.1% . BIDU   +8.9% . ACB   +6.4% . More news on: Arbutus Biopharma Corporation, Danaos Corporation, Tsakos Energy Navigation Limited, Stocks on the move, , Read more ...

GOSS - Gossamer Bio initiates concurrent capital raises

Gossamer Bio (NASDAQ: GOSS ) launches concurrent offerings of common stock and convertible senior notes due 2027. More news on: Gossamer Bio, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

GOSS - Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes Due 2027

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it intends to offer, subject to market and other con...
Previous 10 Next 10